Fasudil - QR Science and TechnologyAlternative Names: Fasudil mesylate
Latest Information Update: 31 Aug 2015
At a glance
- Originator QR Science and Technology
- Class Amines; Anti-ischaemics; Ischaemic heart disorder therapies; Isoquinolines; Small molecules; Sulfonamides
- Mechanism of Action Calcium channel antagonists; Protein kinase C inhibitors; Rho-associated kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebral infarction; Cerebral vasospasm; Ischaemic heart disorders